Humana (HUM) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Humana Reports Second Quarter 2015 Financial Results; Reaffirms 2015 Financial Guidance
July 29, 2015 7:30 AM EDT2Q 2015 EPS of $2.85 includes $1.18 of gain related to sale of Concentra 2Q 2015 Adjusted EPS of $1.67 excludes the Concentra 2Q 2015 gain and compares to managements guidance of $1.60 to $1.65 Reaffirmed full-year 2015 EPS guidance of approximately $9.28 or $7.75 on an Adjusted basis (excluding the year-to-date gain on sale of Concentra of $1.53 per share) 2Q 2015 Medicare Advantage utilization seen as stabilizing and tracking with managements revised expectations Actions taken to improve profitability of individual commercial and state-based contracts businesses
... More
